Clinical Trial: A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07767474) titled 'A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors' on Aug. 03.

Brief Summary: Study ATX-898-101 is a phase 1/2 open-label study evaluating the safety, tolerability, pharmacokinetic, and preliminary efficacy of ATX-898 as monotherapy and in combination with anti-neoplastic agents in selected solid tumors. This study consists of 2 parts. Part 1 evaluates ATX-898 as monotherapy and Part 2 evaluates ATX-898 in combination with anti-neoplastic agents of interest. Both parts will consists of a dose escalation portion and a dose expansion portion.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Adva...